Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
University of California, San Francisco
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
SWOG Cancer Research Network
Northwestern University
National Institutes of Health Clinical Center (CC)